The role of SPP1 + TAMs in cancer: Impact on patient prognosis and future therapeutic targets
International Journal of Cancer · 2025-11 · 157 (9) · 1763-1771
DOI: 10.1002/ijc.70018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 26.06.2025. Verfasst von Xiang Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Outpatient Chemotherapy, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Neoplasms, Osteopontin, Tumor-Associated Macrophages. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: Haiyan Foundation of Harbin Medical University Cancer Hospital, China Postdoctoral Science Foundation, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Tumor‐associated macrophages (TAMs) are a critical population of immune cells that infiltrate the tumor microenvironment (TME) and significantly influence cancer progression, prognosis, and treatment. SPP1 + TAMs represent a tumor‐promoting subset of TAMs characterized by their ability to secrete osteopontin, along with various cytokines and chemokines, and to interact with a diverse array of ligands. Within the tumor microenvironment, SPP1 + TAMs are primarily localized to hypoxic and necrotic regions, as well as along the tumor margins. Studies have shown that SPP1 + TAMs promote tumor angiogenesis, invasion, metastasis, and immunosuppression. The infiltration of SPP1 + TAMs has been associated with poor prognosis in cancer patients. Furthermore, their presence may influence disease progression and treatment response. Targeting SPP1 + TAMs has the potential to reduce immunosuppression and augment immunotherapeutic efficacy, thereby contributing to improved treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Outpatient Chemotherapy, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
Förderung
- Haiyan Foundation of Harbin Medical University Cancer Hospital
- China Postdoctoral Science Foundation
- the National Natural Science Foundation of China
Zitieren
APA
Li, X., Lian, J., & Lu, H. (2025). The role of SPP1 + TAMs in cancer: Impact on patient prognosis and future therapeutic targets. International Journal of Cancer, 157(9), 1763-1771. https://doi.org/10.1002/ijc.70018
Vancouver
Li X, Lian J, Lu H. The role of SPP1 + TAMs in cancer: Impact on patient prognosis and future therapeutic targets. International Journal of Cancer. 2025;157(9):1763-1771. doi:10.1002/ijc.70018
BibTeX
@article{Li2025,
author = {Li, Xiang and Lian, Jie and Lu, Haibo},
title = {The role of SPP1 + TAMs in cancer: Impact on patient prognosis and future therapeutic targets},
journal = {International Journal of Cancer},
year = {2025},
volume = {157},
number = {9},
pages = {1763--1771},
doi = {10.1002/ijc.70018}
}
EUVIMED